These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9274850)

  • 41. [Effect of hemodialysis on the course of blood sugar curve in patients with chronic renal failure].
    Poplawski A; Oleńska T
    Pol Tyg Lek; 1974 Oct; 29(42):1781-3. PubMed ID: 4419200
    [No Abstract]   [Full Text] [Related]  

  • 42. [Erythrocyte surface charges in patients with chronic kidney failure upon regular hemodialysis].
    Shemetov VD; Landar' VA; Gudim TV
    Urol Nefrol (Mosk); 1988; (6):58-9. PubMed ID: 3232268
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen (author's transl)].
    Prejac M; Mikulicic V; Jeren-Struić B; Kozjak D
    Lijec Vjesn; 1980; 102(7-8):386-91. PubMed ID: 6169969
    [No Abstract]   [Full Text] [Related]  

  • 44. [Gentamicin pharmacokinetics during hemodialysis].
    Takasugi M; Hasegawa O; Soejima M; Yu K; Muta T; Matsuura K; Nakashima Y; Kuroiwa A; Kunifuji Y; Nakamura T
    Nihon Jinzo Gakkai Shi; 1984 Nov; 26(11):1509-19. PubMed ID: 6533375
    [No Abstract]   [Full Text] [Related]  

  • 45. An unusual cause of acute unexplained blood loss in a patient on chronic hemodialysis.
    Minocha A
    South Med J; 2008 Dec; 101(12):1280-1. PubMed ID: 19005439
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis.
    Bustamante J; Martin Mateo MC; De Paula de Pedro A; Ortiz Manchado O
    Nephron; 1978; 22(4-6):312-5. PubMed ID: 740091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

  • 48. Amino acid changes during hemodialysis.
    Holbert RD; Herbert J; Pearson JE; Gonzales FM; Bower JD
    J La State Med Soc; 1983 Jun; 135(6):11-2, 14. PubMed ID: 6554292
    [No Abstract]   [Full Text] [Related]  

  • 49. [Levels of plasma pseudocholinesterase in chronic renal insufficiency patients and hemodialysis].
    Vila P; Silla I; Porta J; Fontestad A; Montero Benzo R
    Rev Esp Anestesiol Reanim; 1987; 34(6):431-7. PubMed ID: 3423372
    [No Abstract]   [Full Text] [Related]  

  • 50. The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis.
    Gugliucci A; Schulze J; Kinugasa E; Ogata H; Kimura S
    Clin Chim Acta; 2009 Apr; 402(1-2):209-10. PubMed ID: 19150443
    [No Abstract]   [Full Text] [Related]  

  • 51. [Change in the activity of blood plasma renin in chronic renal insufficiency during treatment with hemodialysis].
    Barsegian BA
    Ter Arkh; 1978; 50(7):127-9. PubMed ID: 715710
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience with long-term (4-12 years) hemodialysis].
    Löcsey L; Kakuk G
    Orv Hetil; 1984 Aug; 125(32):1925-9. PubMed ID: 6472838
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of hemodialysis on serum concentration of isepamicin in a patient with endstage renal failure.
    Kuranari M; Nawata T; Sato Y; Sakata T; Kodama Y; Takeyama M
    Ann Pharmacother; 1993 Oct; 27(10):1284-5. PubMed ID: 8251702
    [No Abstract]   [Full Text] [Related]  

  • 54. [Beta 2 microglobulin in the blood pf patients with chronic renal failure treated by hemodialysis and kidney transplantation].
    Wiecek A; Kokot F; Kochańska-Dziurowicz A; Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1989 Feb; 81(2):100-6. PubMed ID: 2694120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)].
    Loutocký A; Lachmanová J; Tomásek R; Horký K
    Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974
    [No Abstract]   [Full Text] [Related]  

  • 56. [Need of treatment with hemodialysis and kidney transplantation in Norway].
    Fauchald P; Flatmark A; Orjavik O; Brodwall EK; Myhre E
    Tidsskr Nor Laegeforen; 1975 Feb; 95(4):217-20. PubMed ID: 1093283
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of urea kinetic modeling in determining adequacy of hemodialysis.
    Shak CG
    Nephrol News Issues; 1999 Jun; 13(6):14-6. PubMed ID: 10603844
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum proteins and intermittent hemodialysis in patients with chronic renal failure].
    Ozanian V; Kiriakov Z
    Khirurgiia (Sofiia); 1974; 27(2):122-5. PubMed ID: 4425142
    [No Abstract]   [Full Text] [Related]  

  • 59. Trend evaluation of aluminium in uraemic patients on chronic hemodialysis.
    Di Iorio BR; Scarpino L; Bruno A; Confessore A; Gaudiano G; Altieri C; Smilari F; Papaleo D; Cosentino G; Terracciano V
    Nephron; 1995; 71(4):471-2. PubMed ID: 8587634
    [No Abstract]   [Full Text] [Related]  

  • 60. [Zinc in patients with chronic renal insufficiency subjected to periodic maintenance hemodialysis].
    Temes-Montes XL; Picaporte MA; Herrero E; Otero A; Sánchez-Guisande D; Sánchez-Sicilia L
    Rev Clin Esp; 1982 May; 165(3):189-91. PubMed ID: 7134531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.